总合成和MA026的抗肝炎C病毒活性
Satomi Shimura1, Masahiro Ishima, Syo Nakajima
1Department of Applied Biological Science, Tokyo University of Sciences , Noda, Chiba 278-8510, Japan.
Journal of the American Chemical Society
|November 21, 2013
概括
研究人员合成了一种新型化合物MA026,并发现它通过向Claudin-1来抑制C型肝炎病毒 (HCV) 进入. 这种合成使得对HCV治疗方法的进一步研究成为可能.
科学领域:
- 有机化学 有机化学
- 病毒学 病毒学
- 分子生物学分子生物学
背景情况:
- 型肝炎病毒 (HCV) 感染仍然是一个全球性的健康挑战.
- 需要新的抗病毒药物来对抗HCV.
- MA026是一种具有潜在抗HCV活性的脂环皮.
研究的目的:
- 为了实现MA026.2的第一个全合成.
- 为了确定MA026对抗HCV活性的分子标.
主要方法:
- 收的溶液相合成策略.
- 传染性HCV细胞培养试验.
- 体显示查和表面等离子体共振 (SPR) 分析.
主要成果:
- 成功完成MA026.2的总合成.
- MA026以剂量依赖的方式抑制HCV进入肝细胞.
- 克劳丁-1被确定为MA026抗HCV活性的候选标蛋白.
结论:
- 开发的合成方法适用于生成MA026类似物.
- MA026通过向病毒入口,代表了对HCV的有希望的治疗候选者.
- 克劳丁-1 是MA026抗病毒机制的关键媒介.
更多相关视频
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.2K
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
12.9K
相关概念视频
Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
MAPK Signaling Cascades
7.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Hepatitis
99
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
cAMP-dependent Protein Kinase Pathways
7.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K
Viral Hepatitis I: Introduction
28
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
28
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
